clinical trials

Visterra & A*STAR To Bring Dengue Antibody To Clinical Trials

A*STAR's D3 has joined Visterra to bring the dengue monoclonal antibody VIS513 to proof-of-concept clinical trials.

Generon’s Recombinant IL-22 Receives US FDA Clearance For Phase IIa Trials

Following a successful Phase I study, Generon is moving its recombinant antibody F-652 to Phase IIa trials in collaboration with the Memorial Sloan-Kettering Cancer Center.

Prima BioMed Announces Japanese Collaboration

Prima BioMed and Japanese partners NEC and Yamaguchi University are investigating the use of an adjuvant for a potential liver cancer vaccine.

Putting Patients First

What is an academic research organization and how does it benefit patients? We speak to Dr. Teoh Yee Leong, CEO of the Singapore Clinical Research Institute to find out more.

CBMG Raises US$19.6 Million With Private Placement Offering

The proceeds raised will be used to advance clinical trials of CBMG's lymphoma drugs and therapeutic platforms.

Making Pricey Pills Cheaper

Developing new drugs is undeniably expensive. Could big data and innovating funding mechanisms work together to make them more accessible to those who need it most?

Pan-Asian Trials Could Replace Domestic Studies

Improved adherence to ICH guidelines means that data from Asia-wide trials could be extrapolated to specific countries.

Infosys Taps Into The Cloud

Indian multinational company Infosys has launched a cloud-based version of its Clinical Trial Supply Management solution.